MIRXES
LIVE

Serial Number

79207058

Owner

MIRXES PTE. LTD.

Attorney

Joseph Chu

Filing Date

Nov 18, 2016

Add to watchlist:

No watchlists yet
View on USPTO

MIRXES Trademark

Serial Number: 79207058 • Registration: 5440477

MIRXES is a trademark filed by MIRXES PTE. LTD. on November 18, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MIRXES PTE. LTD. (6 trademarks)

2 TUKANG INNOVATION GROVE,

Entity Type: 24

Trademark Details

Filing Date

November 18, 2016

Registration Date

April 10, 2018

Published for Opposition

January 23, 2018

Goods & Services

Diagnostic preparations for medical and veterinary purposes; diagnostic agents for medical and veterinary purposes, namely, reactants for medical and veterinary diagnosis; medical diagnostic kit consisting primarily of diagnostic preparations for medical use; diagnostic products for medical purposes, namely, blood test kits consisting primarily of medical diagnostic reagents and test strips for the diagnosis of cancer, cardiovascular disorders, metabolic disorders, neurological disorders and immune disorders; biological indicators for medical diagnosis; veterinary diagnostic reagents; medical diagnostic kit consisting primarily of diagnostic reagents for medical and veterinary purposes for conducting Real Time Polymerase Chain Reaction assays (RT-PCR); chemical reagents for medical or veterinary laboratory purposes; medical and veterinary diagnostic reagents for use in testing the presence of cancer, cardiovascular disorders, metabolic disorders, neurological disorders and immune disorders; pharmaceutical preparations for the treatment of disorders of the metabolic system; medical diagnostic reagents for testing of body fluids; stem cells for medical and veterinary purposes; substances for use in genetic probe assay kits, namely, medical diagnostic reagents, for medical use; diagnostic preparations for medical purposes; biochemical preparations for diagnostic use, namely, for use in testing the presence of cancer, cardiovascular disorders, metabolic disorders, neurological disorders and immune disorders; products for medical diagnosis, namely, blood test kits consisting primarily of medical diagnostic reagents and test strips for diagnosis of cancer, cardiovascular disorders, metabolic disorders, neurological disorders and immune disorders; diagnostic agents for medical use; test reagents for medical diagnostic use; diagnostic biomarker reagents for medical purposes; chemical preparations for medical diagnostic purposes; chemical preparations for medical use in DNA analysis; chemical products in the nature of biomarker discovery solutions for medical diagnosis and analysis; biological preparations for medical use in the analysis of cell cultures; medical diagnostic preparations for detecting genetic predispositions for medical purposes; medical diagnostic reagents for analytical purposes; synthetic deoxyribonucleic acid and synthetic ribonucleic acid for medical use; nucleic acid amplification reagents for medical use

Research and development of technology in the field of microRNA, DNA, molecular biology, biochemistry, genetic engineering, polymerase chain reactions, agriculture, botany and horticulture; research and development of new products; research and development in the field of microRNA; research and development in the field of microorganisms and cells; research relating to molecular sciences; provision of information and data relating to medical and veterinary research and development; research and development services in the field of antibody technology; research and development services in the field of cell therapy; research and development services in the field of in-vitro fertilization; research and development services in the field of neurodegenerative diseases; research and development services in the field of gene expression systems; chemical laboratory services; laboratory testing of blood, biofluids, stem cells, cancer cells, plants, plant seeds and crop seeds for research; contract scientific research in the field of molecular sciences; laboratory analysis in the field of microRNA, DNA, molecular biology, biochemistry, genetic engineering, polymerase chain reactions, agriculture, botany and horticulture for research; laboratory research in the field of microRNA, DNA, molecular biology, biochemistry, genetic engineering, polymerase chain reactions, agriculture, botany and horticulture; conducting scientific research in the nature of clinical trials for others in the field of microRNA, DNA, molecular biology, biochemistry, genetic engineering polymerase chain reactions, agriculture, botany and horticulture; laboratory research services relating to the field of microRNA technology; biological and biochemical analysis; bioinformatics analysis; veterinary laboratory services; scientific research and development; scientific analysis in the field of molecular biology; scientific research for medical purposes in the area of cancerous diseases; scientific structural and functional analysis of genomes; agricultural research services; scientific laboratory services for agricultural research; biotechnological research relating to agriculture; scientific research in the field of stem cell research; development and testing of computing methods, algorithms computer networks and computer software for others; providing testing and preparation services in relation to immunohistological samples for analysis in research laboratories; technical diagnostic testing services in the field of microRNA, DNA, molecular biology, biochemistry, genetic engineering, polymerase chain reactions, agriculture, botany and horticulture for research; genetic testing for scientific research purposes; medical research services; biomedical research services; biochemistry research services; DNA testing services for scientific research purposes; DNA screening for scientific research purposes; pharmaceutical research services; biological research and analysis; biochemical research and analysis; scientific laboratory services; scientific and technical analysis in the field of microRNA, DNA, molecular biology, biochemistry, genetic engineering, polymerase chain reactions, agriculture, botany and horticulture; technical data analysis services in the field of microRNA, DNA, molecular biology, biochemistry, genetic engineering, polymerase chain reactions, agriculture, botany and horticulture for research; medical research services featuring the analysis of tissues; environmental testing and inspection services; technical consultancy in the field of environmental science; research in the field of environmental protection; providing advisory and consultation services in connection with product testing

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Oct 3, 2024 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Oct 3, 2024 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 30, 2024 APRE
TEAS SECTION 71 & 15 RECEIVED
Jan 31, 2024 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 10, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Sep 17, 2022 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 23, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 23, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 23, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 23, 2022 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 24, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 27, 2018 FICS
FINAL DISPOSITION PROCESSED
Jul 27, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 10, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 10, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 23, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jan 23, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Jan 19, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 3, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 3, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 3, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 18, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 18, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 18, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 18, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 18, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 9, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 9, 2017 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 9, 2017 CHAN
ASSIGNED TO LIE
Dec 9, 2017 ALIE
ASSIGNED TO LIE
Dec 6, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 28, 2017 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 23, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 23, 2017 REAP
REFUSAL PROCESSED BY IB
Jun 24, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 2, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jun 2, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 18, 2017 RFCR
NON-FINAL ACTION WRITTEN
May 17, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
May 17, 2017 MAFR
ASSIGNED TO EXAMINER
May 13, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 13, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 11, 2017 REPR